Scleroderma and Myositis Overview

______ is characterized by progressive fibrosis involving the skin, gastrointestinal tract, and other tissues.

Fibrosis in scleroderma may stem from cytokine-activated ______.

The trigger for Tcell responses in scleroderma remains ______.

Endothelial injury and microvascular disease are prevalent in systemic sclerosis lesions, possibly inducing chronic ______.

The cause of vascular injury in scleroderma remains ______.

______ is commonly called systemic sclerosis.

Systemic sclerosis is commonly known as ______

Scleroderma is characterized by progressive fibrosis involving the ______

Fibrosis in systemic sclerosis may stem from cytokine-activated ______

Endothelial injury and microvascular disease are prevalent in systemic sclerosis lesions, possibly inducing chronic ______

Myositis comprises an uncommon group of disorders characterized by injury and inflammation of mainly the ______ muscles

Dermatomyositis is one of the distinct subtypes of idiopathic inflammatory myopathies - in short ______

______ is often needed to make sure of the diagnosis in Scleroderma.

What type of tests are involved in the evaluation of Scleroderma: Laboratory, imaging, and ______?

______ are drugs that inhibit or prevent immune system activity, used in Scleroderma management.

______ is a blood product containing antibodies derived from donated human plasma, used in Scleroderma treatment.

Management of Scleroderma may involve the need for ______ to confirm the diagnosis.

Evaluation of Scleroderma may require ______ to ensure an accurate diagnosis.